Sydney, Australia, July 28, 2011 - (ABN Newswire) - Novogen Limited's (ASX:NRT.AX) subsidiary, Marshall Edwards, Inc.(NAS:MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced the publication of results from a pre-clinical study of NV-128. This study shows that NV-128 can induce cell death in chemotherapy-resistant ovarian cancer stem cells, providing encouraging data for further study in ovarian cancer.
Anatolia Energy Limited (ASX:AEK.AX) announced an initial JORC Mineral Resource estimate of 17.4Mlb U3O8 for the Temrezli uranium prospect in Turkey. The resource estimate exceeds the exploration tonnage potential expected for the Temrezli deposit, and provides all necessary encouragement for the feasibility study on the establishment of a uranium production facility that can leach the ore in-situ and recover uranium from Temrezli and other deposits.
Waratah Resources Limited (ASX:WGO.AX) has signed a binding Share Sale Agreement to acquire the Okanabora Project in the Republic of Congo. The Project is centred approximately 75 kms southwest of Waratah's existing Youkou project. Recent field work from the Okanabora Project returned results up to 60% Fe2O3. Waratah's immediate goal is to define a JORC inferred resource by Q1 2012 at Youkou and Q2 2012 at Okanabora 2012.
David Jones Limited (ASX:DJS.AX) is launching a new brand campaign titled "WAS. IS. ALWAYS. DAVID JONES" for Spring/Summer 2011 to further enhance its position as the premier department store in Australia. To support the campaign, David Jones is introducing 60 exciting new brands and brand extensions into its business, the vast majority of which are department store exclusive to the Company.
Asia Business News Sydney Tel: +61-2-9247-4344 Tokyo Tel: +81-3-6868-3802 http://www.abnnewswire.net
Copyright (C) 2011 ABN Newswire. All rights reserved.